Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Carmen Criscitiello1, Debora Fumagalli1, Kamal S Saini2, Sherene Loi11Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels; 2Breast Data Centre, Institut Jules Bordet, Brussels, BelgiumAbstract: Tamoxifen was the first targete...

Full description

Bibliographic Details
Main Authors: Carmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-12-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/tamoxifen-in-early-stage-estrogen-receptor-positive-breast-cancer-over-a5927

Internet

http://www.dovepress.com/tamoxifen-in-early-stage-estrogen-receptor-positive-breast-cancer-over-a5927

Similar Items